{
    "clinical_study": {
        "@rank": "55165", 
        "arm_group": [
            {
                "arm_group_label": "Neo Baroreflex Activation Therapy System", 
                "arm_group_type": "Experimental", 
                "description": "Patients are randomized to receive Neo Baroreflex Activation Therapy System device plus optimal medical management."
            }, 
            {
                "arm_group_label": "Medical Management Arm", 
                "arm_group_type": "No Intervention", 
                "description": "Patients are randomized to receive optimal medical management alone."
            }
        ], 
        "brief_summary": {
            "textblock": "The Barostim\u2122 Hypertension Pivotal Trial is a prospective, randomized, controlled trial to\n      demonstrate the safety and efficacy of the Barostim Neo system in subjects with resistant\n      hypertension."
        }, 
        "brief_title": "CVRx Barostim Hypertension Pivotal Trial", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Uncontrolled Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria Highlights:\n\n          -  Age at least 21 years and no more than 80 years at the time of randomization.\n\n          -  On four or more maximally tolerated anti-hypertensive medications, one of which is a\n             diuretic. The antihypertensive medication regimen must remain unchanged for 4 weeks\n             prior to screening and must be expected to remain unchanged for at least 6 months\n             during follow-up.\n\n          -  Protocol defined systolic blood pressure greater than or equal to 160 mmHg.\n\n          -  Protocol defined 24-hour Ambulatory Blood Pressure Monitoring (ABPM) greater than or\n             equal to 135 mmHg.\n\n          -  Serum estimated glomerular filtration rate (eGFR) > 29 mL/min/1.73 m^2.\n\n          -  Appropriate surgical candidate.\n\n          -  Women of childbearing potential must use a medically accepted method of birth control\n             and agree to continue use of this method for the duration of the study.  Women of\n             childbearing potential must have a negative pregnancy test within 14 days prior to\n             randomization.\n\n        Exclusion Criteria Highlights:\n\n          -  Known or suspected baroreflex failure or autonomic neuropathy.\n\n          -  Myocardial infarction, hypertensive crisis, symptomatic orthostatic hypotension,\n             unstable angina, syncope, or cerebral vascular accident within the 3 months.\n\n          -  Hypertension secondary to an identifiable and treatable cause other than sleep apnea.\n\n          -  Prior surgery, radiation, or endovascular stent placement in the carotid sinus\n             region."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "310", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01679132", 
            "org_study_id": "360039"
        }, 
        "intervention": {
            "arm_group_label": "Neo Baroreflex Activation Therapy System", 
            "intervention_name": "Neo Baroreflex Activation Therapy System", 
            "intervention_type": "Device", 
            "other_name": [
                "Neo System", 
                "Barostim Neo System"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Hypertension", 
            "High Blood Pressure", 
            "Blood Pressure", 
            "Cardiovascular Disease", 
            "Resistant Hypertension"
        ], 
        "lastchanged_date": "August 23, 2013", 
        "location": [
            {
                "contact": {
                    "email": "wschwoegler@azheartrythm.com", 
                    "last_name": "Wendy Schwoegler", 
                    "phone": "602-456-2342"
                }, 
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85006"
                    }, 
                    "name": "Arizona Heart Rhythm Research Center"
                }, 
                "investigator": {
                    "last_name": "Vijay Swarup", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "romeroch@usc.edu", 
                    "last_name": "Christian Romero", 
                    "phone": "323-442-5322"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "University of Southern California"
                }, 
                "investigator": {
                    "last_name": "Karen Woo", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cgarey@mfa.gwu.edu", 
                    "last_name": "Cathy Garey", 
                    "phone": "202-741-3168"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20037"
                    }, 
                    "name": "George Washington University"
                }, 
                "investigator": {
                    "last_name": "Gregory Trachiotis", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "carol.stastny@flhosp.org", 
                    "last_name": "Carol Stastny", 
                    "phone": "407-303-5600", 
                    "phone_ext": "1103439"
                }, 
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32803"
                    }, 
                    "name": "Florida Hospital Cardiovascular Institute"
                }, 
                "investigator": {
                    "last_name": "Harischandra Karunaratne", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "courtneyelee@tgh.org", 
                    "last_name": "Courtney Lee", 
                    "phone": "813-353-8535"
                }, 
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33606"
                    }, 
                    "name": "Florida Cardiovascular Institute"
                }, 
                "investigator": {
                    "last_name": "Fadi Matar", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "deanna.benoit@cardio.com", 
                    "last_name": "Deanna Benoit", 
                    "phone": "985-873-5613"
                }, 
                "facility": {
                    "address": {
                        "city": "Houma", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70361"
                    }, 
                    "name": "Cardiovascular Institute of the South"
                }, 
                "investigator": {
                    "last_name": "Richard Abben", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jlalonde@cvrcnm.com", 
                    "last_name": "Jennifer LaLonde", 
                    "phone": "231-487-9185"
                }, 
                "facility": {
                    "address": {
                        "city": "Petosky", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49770"
                    }, 
                    "name": "Cardiac and Vascular Research Center of Northern Michigan"
                }, 
                "investigator": {
                    "last_name": "Harry Colfer", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tgauthier@mcvi.com", 
                    "last_name": "Tacey Gauthier", 
                    "phone": "989-907-8031"
                }, 
                "facility": {
                    "address": {
                        "city": "Saginaw", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48601"
                    }, 
                    "name": "Michigan CardioVascular Institute"
                }, 
                "investigator": {
                    "last_name": "Naveed Akhtar", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "luzviminda.dizon@umcsn.com", 
                    "last_name": "Luzviminda Dizon", 
                    "phone": "702-383-2585"
                }, 
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89102"
                    }, 
                    "name": "University Medical Center of Southern Nevada"
                }, 
                "investigator": {
                    "last_name": "Chowdhury Ahsan", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bmiller@okheart.com", 
                    "last_name": "Bonnie Miller", 
                    "phone": "405-608-1280"
                }, 
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73120"
                    }, 
                    "name": "Oklahoma Heart hospital"
                }, 
                "investigator": {
                    "last_name": "Branislov Schifferdecker", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sbernard@wpahs.org", 
                    "last_name": "Sheila Bernardini", 
                    "phone": "412-359-5600", 
                    "phone_ext": "1103439"
                }, 
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15212"
                    }, 
                    "name": "Allegheny General Hospital"
                }, 
                "investigator": {
                    "last_name": "Srinivas Murali", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jeff.kaliebe@aspirus.org", 
                    "last_name": "Jeff Kaliebe", 
                    "phone": "715-847-2273", 
                    "phone_ext": "52639"
                }, 
                "facility": {
                    "address": {
                        "city": "Wausau", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "54401"
                    }, 
                    "name": "Aspirus Wausau Hospital"
                }, 
                "investigator": {
                    "last_name": "German Larrain", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "CVRx Barostim Hypertension Pivotal Trial", 
        "overall_contact": {
            "email": "tmoore@cvrx.com", 
            "last_name": "Tom Moore", 
            "phone": "763-416-2352"
        }, 
        "overall_official": [
            {
                "affiliation": "The University of Chicago Medicine", 
                "last_name": "George Bakris, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Rochester", 
                "last_name": "John Bisognano, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Keck School of Medicine of the University of Southern California", 
                "last_name": "Fred Weaver, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Ohio State University", 
                "last_name": "William Abraham, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To demonstrate the safety of the Neo system by reporting all adverse events that are complications between implant and 30 days post-implant in the device arm.  The incidence of adverse events will be categorized by relatedness.", 
                "measure": "Primary Safety Objective", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "description": "To demonstrate a significant reduction between the two treatment arms of protocol defined automated office cuff systolic blood pressure (SBP) from baseline to 6 months post-activation.", 
                "measure": "Primary Efficacy Objective", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01679132"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To demonstrate a significant reduction within the device arm of office cuff systolic blood pressure (SBP) between baseline and 12 months post-activation.", 
                "measure": "Secondary Efficacy Objective 1", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "To demonstrate a significant reduction within the device arm of 24-hour ambulatory systolic blood pressure (SBP) between baseline and 12 months post-activation.", 
                "measure": "Secondary Efficacy Objective 2", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "To demonstrate the safety of the Neo system by reporting all hypertensive emergencies from activation to 6 months post activation.  The incidence of hypertensive emergencies will be categorized by study arm.", 
                "measure": "Secondary Safety Objective", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }
        ], 
        "source": "CVRx, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "CVRx, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}